Clinical Trials

470 enrolled

Phase 2/3 Active not recruiting

Pancreatic Neoplasms

NCT04559139 2026-03-19

Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

186 enrolled

Phase 2/3 Active not recruiting

Gallbladder Neoplasms

NCT06115499 2026-01-07

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

10 enrolled

Pancreatic Neoplasms

NCT06361888 2025-12-30

A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer

502 enrolled

Pancreatic Neoplasms

NCT06783140 2025-12-05

PLATINUM-CAN

10 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT06214572 2025-04-11

RUGB

249 enrolled

Phase 2/3 Not yet recruiting

Biliary Tract Neoplasms, Gallbladder Neoplasms

NCT06923475 2025-04-11

NEODISCO

150 enrolled

Phase 2/3 Active not recruiting

Cholangiocarcinoma, Klatskin Tumor

NCT02867865 2025-03-13

POLCAGB

124 enrolled

Gallbladder Neoplasms

NCT06037980 2025-02-17

PURITY

300 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT03512756 2024-11-06

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

Phase 2/3 Terminated

130 enrolled 13 charts

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT05254171 2024-11-06

ASPIRE

600 enrolled

Pancreatic Neoplasms

NCT03721744 2024-04-03

A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer

336 enrolled

Pancreatic Neoplasms

NCT04066491 2023-11-14

Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC

Phase 2/3 Terminated

309 enrolled 17 charts

Biliary Tract Neoplasms, Camurati-Engelmann Syndrome, Gallbladder Neoplasms, Cholangiocarcinoma

NCT04037241 2022-04-01

Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases

Malignant Tumor of Pancreas Metastatic to Liver

NCT03086993 2022-03-24

Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma

Phase 2/3 Unknown

295 enrolled

Bile Duct Neoplasms, Cholangiocarcinoma

NCT00112658 2021-03-08

Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

342 enrolled

Pancreatic Neoplasms

NCT02172976 2020-09-02

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

40 enrolled

Pancreatic Neoplasms

NCT03610100 2019-10-29

ACELARATE

Phase 2/3 Suspended

328 enrolled

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT02527772 2019-06-04

LD-FOX4/HCC

Carcinoma, Hepatocellular

NCT02534337 2019-06-04

Gemcitabine Plus Oxaliplatin Versus Oxaliplatin Plus Fluorouracil/Leucovorin for Hepatocellular Carcinoma

Carcinoma, Hepatocellular

NCT00304135 2016-05-30

Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery

34 enrolled

Bile Duct Neoplasms, Gallbladder Neoplasms, Liver Neoplasms

NCT01598584 2015-09-28

Mirtazapine Plus Gemcitabine Versus Gemcitabine in Metastasis Pancreatic Cancer

Pancreatic Neoplasms

NCT00785421 2015-01-08

PROSPECT

312 enrolled

Pancreatic Neoplasms

NCT00939848 2014-10-27

ABC-03

124 enrolled

Biliary Tract Neoplasms

NCT01065870 2014-01-29

Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)

Phase 2/3 Unknown

64 enrolled

Pancreatic Neoplasms

NCT00064207 2012-09-24

Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer

97 enrolled

Pancreatic Neoplasms

NCT00960284 2012-01-13

PACT-7

102 enrolled

Pancreatic Neoplasms

NCT00192712 2010-11-10

Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer

20 enrolled